Sorafenib in BAC or Never-Smokers With Lung Adenocarcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Lung Cancer
Related studies linked through entity extraction aliases.
First-Line Treatment of A Comparison of 2 Treatments in Elderly Patients With Advanced NSCLC
- Status
- COMPLETED
- Phase
- PHASE2
First-line Gefitinib Versus Chemotherapy for Lung Adenocarcinoma in Never Smoker
- Status
- COMPLETED
- Phase
- PHASE3
Disease-Specific Questionnaire in Assessing Quality of Life in Patients With Gastrointestinal-Related Neuroendocrine Tumors
- Status
- UNKNOWN
- Phase
- N/A
Pemetrexed Disodium With or Without Sorafenib as Second-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Cancer Prevention and Treatment Demonstration for Ethnic and Racial Minorities
- Status
- COMPLETED
- Phase
- N/A
Weekly Paclitaxel Plus Gemcitabine as Second-line in Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Gemcitabine Plus Oxaliplatin in Advanced Stage IIIB/IV Non Small Cell Lung Cancer (NSCLC)
- Status
- UNKNOWN
- Phase
- PHASE2
Adjuvant Gemcitabine Plus Oxaliplatin Versus Gemcitabine Plus Cisplatin for Completely Resected Stage IB/II/IIIA NSCLC
- Status
- UNKNOWN
- Phase
- PHASE2
Pre-operative Chemotherapy Versus Concurrent Chemoradiotherapy in N2 Positive IIIA Non Small Cell Lung Cancer (NSCLC)
- Status
- UNKNOWN
- Phase
- PHASE2
Gefitinib With or Without Simvastatin in Non-Small Cell Lung Cancer (NSCLC)
- Status
- COMPLETED
- Phase
- PHASE2
Follow-Up Study of Subjects Previously Enrolled in Poxviral Vector Gene Transfer Studies
- Status
- RECRUITING
- Phase
- N/A
Glucose Metabolism in Patients With Non-Small Cell Lung Cancer Treated With Targeted Therapy and Chemotherapy
- Status
- COMPLETED
- Phase
- N/A
S0424 - Carcinogens in Lung Tissue From Smokers (Closed to Entry as of 7/15/07) and Non-Smokers With Newly Diagnosed Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- N/A
Six-Minute Walk Test in Patients at High Risk for Complications From Lung Resection
- Status
- UNKNOWN
- Phase
- N/A
Carboplatin, Irinotecan, and Radiation Therapy Followed By Docetaxel in Treating Patients With Newly Diagnosed Stage III Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Iodine I 131 Monoclonal Antibody 3F8 in Treating Patients With Central Nervous System Cancer or Leptomeningeal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
S0636: Erlotinib and Bevacizumab in Never-Smokers With Stage IIIB or Stage IV Primary Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Fluorine F 18 FEQA in Patients With Stage III or Stage IV Non-Small Cell Lung Cancer and in Healthy Participants
- Status
- TERMINATED
- Phase
- NA
Pharmacogenomic Study in Patients of Lung, Colorectal and Head/Neck Cancers Receiving Chemotherapy
- Status
- COMPLETED
- Phase
- N/A